Herriot Tabuteau

Person

New York, NY, US

People

Patents Grantslast 30 patents

Information Patent Grant
Bupropion dosage forms with reduced food and alcohol dosing effects
- Patent number 12,310,961
- Issue date May 27, 2025
- Antecip Bioventures II LLC
- Herriot Tabuteau
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pharmaceutical compositions comprising a tolfenamic acid
- Patent number 12,268,693
- Issue date Apr 8, 2025
- AXSOME THERAPEUTICS, INC.
- Herriot Tabuteau
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bupropion dosage forms with reduced food and alcohol dosing effects
- Patent number 12,263,161
- Issue date Apr 1, 2025
- Antecip Bioventures II LLC
- Herriot Tabuteau
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of administering solriamfetol to lactating women
- Patent number 12,263,145
- Issue date Apr 1, 2025
- Axsome Malta Ltd.
- Herriot Tabuteau
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of reboxetine to treat narcolepsy
- Patent number 12,246,023
- Issue date Mar 11, 2025
- AXSOME THERAPEUTICS, INC.
- Herriot Tabuteau
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bupropion dosage forms with reduced food and alcohol dosing effects
- Patent number 12,239,642
- Issue date Mar 4, 2025
- Antecip Bioventures II LLC
- Herriot Tabuteau
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds and combinations thereof for treating neurological and ps...
- Patent number 12,194,005
- Issue date Jan 14, 2025
- Antecip Bioventures II LLC
- Herriot Tabuteau
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bupropion as a modulator of drug activity
- Patent number 12,194,006
- Issue date Jan 14, 2025
- Antecip Bioventures II LLC
- Herriot Tabuteau
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combination of dextromethorphan and bupropion for treating depression
- Patent number 12,194,036
- Issue date Jan 14, 2025
- Antecip Bioventures II LLC
- Herriot Tabuteau
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pharmaceutical compositions comprising bupropion and cysteine
- Patent number 12,156,914
- Issue date Dec 3, 2024
- AXSOME THERAPEUTICS, INC.
- Herriot Tabuteau
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds and combinations thereof for treating neurological and ps...
- Patent number 12,146,889
- Issue date Nov 19, 2024
- Antecip Bioventures II LLC
- Herriot Tabuteau
- G01 - MEASURING TESTING
Information Patent Grant
Compounds and combinations thereof for treating neurological and ps...
- Patent number 12,138,260
- Issue date Nov 12, 2024
- Antecip Bioventures II LLC
- Herriot Tabuteau
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pharmaceutical compositions comprising meloxicam
- Patent number 12,128,052
- Issue date Oct 29, 2024
- AXSOME THERAPEUTICS, INC.
- Herriot Tabuteau
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of reboxetine to treat narcolepsy
- Patent number 12,115,165
- Issue date Oct 15, 2024
- AXSOME THERAPEUTICS, INC.
- Herriot Tabuteau
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bupropion as a modulator of drug activity
- Patent number 12,109,178
- Issue date Oct 8, 2024
- Antecip Bioventures II LLC
- Herriot Tabuteau
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of administering solriamfetol to lactating women
- Patent number 12,102,609
- Issue date Oct 1, 2024
- AXSOME MALTA LTD.
- Herriot Tabuteau
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Dosage forms and methods for enantiomerically enriched or pure bupr...
- Patent number 12,102,606
- Issue date Oct 1, 2024
- AXSOME THERAPEUTICS, INC.
- Herriot Tabuteau
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of administering solriamfetol to lactating women
- Patent number 12,090,126
- Issue date Sep 17, 2024
- Axsome Malta Ltd.
- Herriot Tabuteau
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of administering solriamfetol to lactating women
- Patent number 12,064,411
- Issue date Aug 20, 2024
- Axsome Malta Ltd.
- Herriot Tabuteau
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds and combinations thereof for treating neurological and ps...
- Patent number 12,042,473
- Issue date Jul 23, 2024
- Antecip Bioventures II LLC
- Herriot Tabuteau
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of administering solriamfetol to lactating women
- Patent number 12,036,194
- Issue date Jul 16, 2024
- Axsome Malta Ltd.
- Herriot Tabuteau
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of poor metabolizers of dextromethorphan with a combinati...
- Patent number 12,036,191
- Issue date Jul 16, 2024
- Antecip Bioventures II LLC
- Herriot Tabuteau
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of administering solriamfetol to lactating women
- Patent number 12,005,036
- Issue date Jun 11, 2024
- Axsome Malta Ltd.
- Herriot Tabuteau
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pharmaceutical compositions comprising meloxicam
- Patent number 12,005,118
- Issue date Jun 11, 2024
- AXSOME THERAPEUTICS, INC.
- Herriot Tabuteau
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pharmaceutical compositions comprising meloxicam
- Patent number 11,998,552
- Issue date Jun 4, 2024
- AXSOME THERAPEUTICS, INC.
- Herriot Tabuteau
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of poor metabolizers of dextromethorphan with a combinati...
- Patent number 11,986,444
- Issue date May 21, 2024
- Antecip Bioventures II LLC
- Herriot Tabuteau
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bupropion as a modulator of drug activity
- Patent number 11,969,421
- Issue date Apr 30, 2024
- Antecip Bioventures II LLC
- Herriot Tabuteau
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions for delivery of reboxetine
- Patent number 11,957,686
- Issue date Apr 16, 2024
- AXSOME THERAPEUTICS, INC.
- Herriot Tabuteau
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pharmaceutical compositions comprising meloxicam
- Patent number 11,944,683
- Issue date Apr 2, 2024
- AXSOME THERAPEUTICS, INC.
- Herriot Tabuteau
- C08 - ORGANIC MACROMOLECULAR COMPOUNDS THEIR PREPARATION OR CHEMICAL WORKING-...
Information Patent Grant
Bupropion dosage forms with reduced food and alcohol dosing effects
- Patent number 11,925,636
- Issue date Mar 12, 2024
- Antecip Bioventures II LLC
- Herriot Tabuteau
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
MICROPARTICLES CONTAINING BUPROPION
- Publication number 20250161239
- Publication date May 22, 2025
- AXSOME THERAPEUTICS, INC.
- Herriot Tabuteau
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF REBOXETINE TO TREAT NARCOLEPSY
- Publication number 20250161316
- Publication date May 22, 2025
- AXSOME THERAPEUTICS, INC.
- Herriot Tabuteau
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF PROVIDING SOLRIAMFETOL THERAPY TO SUBJECTS WITH IMPAIRED...
- Publication number 20250152548
- Publication date May 15, 2025
- Axsome Malta Ltd.
- Katayoun Zomorodi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DOSAGE FORMS AND METHODS FOR ENANTIOMERICALLY ENRICHED OR PURE BUPR...
- Publication number 20250127732
- Publication date Apr 24, 2025
- AXSOME THERAPEUTICS, INC.
- Herriot Tabuteau
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION OF DEXTROMETHORPHAN AND BUPROPION FOR TREATING DEPRESSION
- Publication number 20250114349
- Publication date Apr 10, 2025
- Antecip Bioventures II LLC
- Herriot Tabuteau
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS AND COMBINATIONS THEREOF FOR TREATING NEUROLOGICAL AND PS...
- Publication number 20250114348
- Publication date Apr 10, 2025
- Antecip Bioventures II LLC
- Herriot Tabuteau
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BUPROPION AS A MODULATOR OF DRUG ACTIVITY
- Publication number 20250090521
- Publication date Mar 20, 2025
- Antecip Bioventures II LLC
- Herriot Tabuteau
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS AND COMBINATIONS THEREOF FOR TREATING NEUROLOGICAL AND PS...
- Publication number 20250073188
- Publication date Mar 6, 2025
- Antecip Bioventures II LLC
- Herriot Tabuteau
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS FOR DELIVERY OF REBOXETINE
- Publication number 20250064820
- Publication date Feb 27, 2025
- AXSOME THERAPEUTICS, INC.
- Herriot Tabuteau
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS AND COMBINATIONS THEREOF FOR TREATING NEUROLOGICAL AND PS...
- Publication number 20250064797
- Publication date Feb 27, 2025
- Antecip Bioventures II LLC
- Herriot Tabuteau
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF ADMINISTERING SOLRIAMFETOL TO LACTATING WOMEN
- Publication number 20250041251
- Publication date Feb 6, 2025
- AXSOME MALTA LTD.
- Herriot Tabuteau
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL COMPOSITIONS COMPRISING BUPROPION AND CYSTEINE
- Publication number 20250041426
- Publication date Feb 6, 2025
- AXSOME THERAPEUTICS, INC.
- Herriot Tabuteau
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BUPROPION AS A MODULATOR OF DRUG ACTIVITY
- Publication number 20250032432
- Publication date Jan 30, 2025
- Antecip Bioventures II LLC
- Herriot Tabuteau
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS AND COMBINATIONS THEREOF FOR TREATING NEUROLOGICAL AND PS...
- Publication number 20250025458
- Publication date Jan 23, 2025
- Antecip Bioventures II LLC
- Herriot Tabuteau
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL COMPOSITIONS COMPRISING MELOXICAM
- Publication number 20250009754
- Publication date Jan 9, 2025
- AXSOME THERAPEUTICS, INC.
- Herriot Tabuteau
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS AND COMBINATIONS THEREOF FOR TREATING NEUROLOGICAL AND PS...
- Publication number 20250012821
- Publication date Jan 9, 2025
- Antecip Bioventures II LLC
- Herriot Tabuteau
- G01 - MEASURING TESTING
Information Patent Application
METHODS OF ADMINISTERING SOLRIAMFETOL TO LACTATING WOMEN
- Publication number 20250000825
- Publication date Jan 2, 2025
- Axsome Malta Ltd.
- Herriot Tabuteau
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF REBOXETINE TO TREAT NARCOLEPSY
- Publication number 20240415842
- Publication date Dec 19, 2024
- AXSOME THERAPEUTICS, INC.
- Herriot Tabuteau
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BUPROPION AS A MODULATOR OF DRUG ACTIVITY
- Publication number 20240408040
- Publication date Dec 12, 2024
- Antecip Bioventures II LLC
- Herriot Tabuteau
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BUPROPION AND DEXTROMETHORPHAN FOR REDUCTION OF SUICIDE RISK IN DEP...
- Publication number 20240390297
- Publication date Nov 28, 2024
- Antecip Bioventures II LLC
- Herriot Tabuteau
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF MODULATING TETRABENAZINE METABOLITES PLASMA LEVELS USING...
- Publication number 20240358696
- Publication date Oct 31, 2024
- AXSOME THERAPEUTICS, INC.
- Herriot Tabuteau
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BUPROPION AS A MODULATOR OF DRUG ACTIVITY
- Publication number 20240358658
- Publication date Oct 31, 2024
- Antecip Bioventures II LLC
- Herriot Tabuteau
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF ADMINISTERING SOLRIAMFETOL TO LACTATING WOMEN
- Publication number 20240350435
- Publication date Oct 24, 2024
- Axsome Malta Ltd.
- Herriot Tabuteau
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL COMPOSITIONS COMPRISING MELOXICAM
- Publication number 20240307408
- Publication date Sep 19, 2024
- AXSOME THERAPEUTICS, INC.
- Herriot Tabuteau
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF REBOXETINE TO TREAT NARCOLEPSY
- Publication number 20240307407
- Publication date Sep 19, 2024
- AXSOME THERAPEUTICS, INC.
- Herriot Tabuteau
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS AND COMBINATIONS THEREOF FOR TREATING NEUROLOGICAL AND PS...
- Publication number 20240299320
- Publication date Sep 12, 2024
- Antecip Bioventures II LLC
- Herriot Tabuteau
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF POOR METABOLIZERS OF DEXTROMETHORPHAN WITH A COMBINATI...
- Publication number 20240299319
- Publication date Sep 12, 2024
- Antecip Bioventures II LLC
- Herriot Tabuteau
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DOSAGE FORMS AND METHODS FOR ENANTIOMERICALLY ENRICHED OR PURE BUPR...
- Publication number 20240293342
- Publication date Sep 5, 2024
- AXSOME THERAPEUTICS, INC.
- Herriot Tabuteau
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DOSAGE FORMS AND METHODS FOR ENANTIOMERICALLY ENRICHED OR PURE BUPR...
- Publication number 20240277635
- Publication date Aug 22, 2024
- AXSOME THERAPEUTICS, INC.
- Herriot Tabuteau
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL COMPOSITIONS COMPRISING BUPROPION AND CYSTEINE
- Publication number 20240277849
- Publication date Aug 22, 2024
- AXSOME THERAPEUTICS, INC.
- Herriot Tabuteau
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Herriot Tabuteau

Person

Patents Grantslast 30 patents

Bupropion dosage forms with reduced food and alcohol dosing effects

Pharmaceutical compositions comprising a tolfenamic acid

Bupropion dosage forms with reduced food and alcohol dosing effects

Methods of administering solriamfetol to lactating women

Use of reboxetine to treat narcolepsy

Bupropion dosage forms with reduced food and alcohol dosing effects

Compounds and combinations thereof for treating neurological and ps...

Bupropion as a modulator of drug activity

Combination of dextromethorphan and bupropion for treating depression

Pharmaceutical compositions comprising bupropion and cysteine

Compounds and combinations thereof for treating neurological and ps...

Compounds and combinations thereof for treating neurological and ps...

Pharmaceutical compositions comprising meloxicam

Use of reboxetine to treat narcolepsy

Bupropion as a modulator of drug activity

Methods of administering solriamfetol to lactating women

Dosage forms and methods for enantiomerically enriched or pure bupr...

Methods of administering solriamfetol to lactating women

Methods of administering solriamfetol to lactating women

Compounds and combinations thereof for treating neurological and ps...

Methods of administering solriamfetol to lactating women

Treatment of poor metabolizers of dextromethorphan with a combinati...

Methods of administering solriamfetol to lactating women

Pharmaceutical compositions comprising meloxicam

Pharmaceutical compositions comprising meloxicam

Treatment of poor metabolizers of dextromethorphan with a combinati...

Bupropion as a modulator of drug activity

Compositions for delivery of reboxetine

Pharmaceutical compositions comprising meloxicam

Bupropion dosage forms with reduced food and alcohol dosing effects

Patents Applicationslast 30 patents

MICROPARTICLES CONTAINING BUPROPION

USE OF REBOXETINE TO TREAT NARCOLEPSY

METHODS OF PROVIDING SOLRIAMFETOL THERAPY TO SUBJECTS WITH IMPAIRED...

DOSAGE FORMS AND METHODS FOR ENANTIOMERICALLY ENRICHED OR PURE BUPR...

COMBINATION OF DEXTROMETHORPHAN AND BUPROPION FOR TREATING DEPRESSION

COMPOUNDS AND COMBINATIONS THEREOF FOR TREATING NEUROLOGICAL AND PS...

BUPROPION AS A MODULATOR OF DRUG ACTIVITY

COMPOUNDS AND COMBINATIONS THEREOF FOR TREATING NEUROLOGICAL AND PS...

COMPOSITIONS FOR DELIVERY OF REBOXETINE

COMPOUNDS AND COMBINATIONS THEREOF FOR TREATING NEUROLOGICAL AND PS...

METHODS OF ADMINISTERING SOLRIAMFETOL TO LACTATING WOMEN

PHARMACEUTICAL COMPOSITIONS COMPRISING BUPROPION AND CYSTEINE

BUPROPION AS A MODULATOR OF DRUG ACTIVITY

COMPOUNDS AND COMBINATIONS THEREOF FOR TREATING NEUROLOGICAL AND PS...

PHARMACEUTICAL COMPOSITIONS COMPRISING MELOXICAM

COMPOUNDS AND COMBINATIONS THEREOF FOR TREATING NEUROLOGICAL AND PS...

METHODS OF ADMINISTERING SOLRIAMFETOL TO LACTATING WOMEN

USE OF REBOXETINE TO TREAT NARCOLEPSY

BUPROPION AS A MODULATOR OF DRUG ACTIVITY

BUPROPION AND DEXTROMETHORPHAN FOR REDUCTION OF SUICIDE RISK IN DEP...

METHODS OF MODULATING TETRABENAZINE METABOLITES PLASMA LEVELS USING...

BUPROPION AS A MODULATOR OF DRUG ACTIVITY

METHODS OF ADMINISTERING SOLRIAMFETOL TO LACTATING WOMEN

PHARMACEUTICAL COMPOSITIONS COMPRISING MELOXICAM

USE OF REBOXETINE TO TREAT NARCOLEPSY

COMPOUNDS AND COMBINATIONS THEREOF FOR TREATING NEUROLOGICAL AND PS...

TREATMENT OF POOR METABOLIZERS OF DEXTROMETHORPHAN WITH A COMBINATI...

DOSAGE FORMS AND METHODS FOR ENANTIOMERICALLY ENRICHED OR PURE BUPR...

DOSAGE FORMS AND METHODS FOR ENANTIOMERICALLY ENRICHED OR PURE BUPR...

PHARMACEUTICAL COMPOSITIONS COMPRISING BUPROPION AND CYSTEINE